https://catalystalert.io/drug/8a8a04e6-4a34-4855-ad7c-4d730fcc0805
Sorivudine - Phase 3 | CELG-RI Pipeline | CatalystAlert
Sorivudine (investigational) is a Phase 3 drug candidate from BRISTOL MYERS SQUIBB CO. Target indication: HIV Infections. Track clinical trial progress and FDA...
sorivudinephasecelgpipeline